NEO NeoGenomics, Inc. - Common Stock
NASDAQ · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Lip 28, 2026
$18,47
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$7,0752tyg. minimum
$20,0552tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$2.36B
P/E
-77.9
Przychody
$727M
Twoje odznaki
Zakres 52 tyg.
$7–$20
Ocena Analityków
BUY
Cena Docelowa
$20
P/E
-77.9
ROE
-12.8%
Marża Zysku Netto
-6.8%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
NEO Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$18.47
Kapitalizacja Rynkowa (MRQ)
$2.36B
P/E
-77.9
Przychody
$727M
ROE
-12.8%
D/E Dług/Kapitał (MRQ)
0.5
Zakres 52 tyg.
$7–$20
NEO Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O NeoGenomics, Inc. - Common Stock Przegląd firmy z Wikipedii
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.
## History
NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.
In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.
In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.
In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.
In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealth Care
branżaHealth Care
pracownicy2 500
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$727M2016-12-31 → 2025-12-31
Wolny przepływ pieniężny$-22M2017-12-31 → 2025-12-31
Marża netto-6.8%2019-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | NEO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E | -77.9średnia z 5 lat ≈-73.2 | ≈-73.2 | · | · | |
| P/S (TTM) | 3.1średnia z 5 lat ≈3.8 | ≈3.8 | 1.1 | Zawyżona wycena | |
| P/B (MRQ) | 3.0średnia z 5 lat ≈2.2 | ≈2.2 | 2.4 | Wartość godziwa | |
| EV / EBITDA | -22.2 | · | · | · | |
| Cena / FCF (TTM) | -321.2średnia z 5 lat ≈-50.3 | ≈-50.3 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 107.2średnia z 5 lat ≈-125.0 | ≈-125.0 | 13.5 | Zawyżona wycena | |
| EV / Revenue (EV / Przychody) | 3.5 | · | · | · | |
| EV / FCF | -118.3 | · | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 4.6średnia z 5 lat ≈40.2 | ≈40.2 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | NEO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 43.9%średnia z 5 lat ≈40.8% | ≈40.8% | 32.6% | Najwyższa półka | |
| Marża Operacyjna (TTM) | -8.9%średnia z 5 lat ≈-20.7% | ≈-20.7% | 4.0% | Słaby | |
| EBITDA Margin (Marża EBITDA) | -15.9%średnia z 5 lat ≈-20.7% | ≈-20.7% | 4.5% | Słaby | |
| Marża przed opodatkowaniem (TTM) | -7.1%średnia z 5 lat ≈-15.6% | ≈-15.6% | 3.3% | Słaby | |
| Marża Zysku Netto (TTM) | -6.8%średnia z 5 lat ≈-14.3% | ≈-14.3% | 2.4% | Słaby | |
| ROA | -7.2%średnia z 5 lat ≈-5.1% | ≈-5.1% | 1.8% | Słaby | |
| ROE | -12.8%średnia z 5 lat ≈-9.2% | ≈-9.2% | 3.3% | Słaby | |
| ROIC | -9.6%średnia z 5 lat ≈-9.3% | ≈-9.3% | 5.0% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | NEO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.5 | · | 0.3 | Wysokie zadłużenie | |
| Wskaźnik bieżący (MRQ) | 3.6średnia z 5 lat ≈5.4 | ≈5.4 | 1.5 | Silna płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 3.6średnia z 5 lat ≈3.9 | ≈3.9 | 1.2 | Silna płynność | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.5 | · | 0.4 | Wysokie zadłużenie |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | NEO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 10.1%średnia z 5 lat ≈10.4% | ≈10.4% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 12.6%średnia z 5 lat ≈11.2% | ≈11.2% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 10.3% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | NEO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.5średnia z 5 lat ≈0.4 | ≈0.4 | 1.6 | Słaby | |
| Inventory Turnover (Rotacja zapasów) | 14.9średnia z 5 lat ≈13.7 | ≈13.7 | · | · | |
| Receivables Turnover (Rotacja należności) | 4.7średnia z 5 lat ≈4.6 | ≈4.6 | 8.4 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$290.9K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
55.4%
Następny raport
Paź 26, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 27, 2026 | $0.05 | $0.03 | 51.1% |
| 31 marca 2026 | $0.01 | $0.01 | — | |
| 31 grudnia 2025 | $0.06 | $0.04 | 53.5% | |
| 30 września 2025 | $0.03 | $0.02 | 40.8% | |
| 30 czerwca 2025 | $0.03 | $0.02 | 31.6% | |
| 31 marca 2025 | $0.00 | $-0.01 | 100.0% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Cost of Revenue | $413M | $370M | $347M | $322M | $297M | $259M | $212M | $149M | $138M | $134M | $56M | $46M | |
| Gross Profit | $314M | $290M | $245M | $188M | $187M | $186M | $197M | $127M | $102M | $98M | $44M | $41M | |
| R&D Expense | $37M | $31M | $27M | $30M | $22M | $8M | $8M | $3M | $4M | $5M | $4M | $3M | |
| SG&A Expense | $273M | $260M | $243M | $243M | $221M | $144M | $128M | $85M | $70M | $64M | $34M | $24M | |
| Operating Expenses | $430M | $382M | $352M | $346M | $306M | $200M | $184M | $117M | $99M | $96M | $49M | $38M | |
| Operating Income | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | $10M | $3M | $2M | $-6M | $2M | |
| Interest Expense | · | · | $7M | $8M | $8M | $7M | $4M | $6M | $6M | · | $854.0K | $985.0K | |
| Interest Income | $9M | $18M | $17M | $6M | $3M | · | · | · | · | · | · | · | |
| Other Non-op | $296.0K | $-379.0K | $644.0K | $-213.0K | $-499.0K | $8M | $-5M | $14.0K | $-12.0K | $0 | $2M | $56.0K | |
| Pretax Income | $-110M | $-81M | $-97M | $-159M | $-15M | $-14M | $4M | $4M | $-3M | $-8M | $-4M | $1M | |
| Income Tax | $-2M | $-2M | $-9M | $-15M | $-7M | $-18M | $-4M | $1M | $-2M | $-2M | $-2M | $157.0K | |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| Shares (Basic) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 108,579,000 | 100,470,000 | 85,618,000 | 79,426,000 | 77,542,000 | 60,526,000 | 53,483,000 | |
| Shares (Diluted) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 111,794,000 | 103,615,000 | 91,568,000 | 79,426,000 | 77,542,000 | 60,526,000 | 56,016,000 | |
| EBITDA | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | · | $2M | · | $-6M | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $367M | $342M | $263M | $317M | $229M | $173M | $10M | $13M | $13M | $23M | $34M | |
| Receivables | $159M | $151M | $131M | $120M | $112M | $107M | $94M | $77M | $60M | $56M | $49M | $20M | |
| Inventory | $29M | $27M | $24M | $24M | $23M | $30M | $14M | $9M | $7M | $6M | $5M | $3M | |
| Prepaid Expense | $21M | $20M | $18M | $15M | $12M | $12M | $6M | $8M | $5M | $5M | $5M | $1M | |
| Other Current Assets | $7M | $12M | $8M | $8M | $8M | $5M | $3M | $561.0K | $1M | · | · | · | |
| Current Assets | $376M | $596M | $597M | $605M | $682M | $449M | $291M | $104M | $86M | $79M | $82M | $59M | |
| PP&E (Net) | $85M | $94M | $92M | $102M | $109M | $86M | $64M | $61M | $37M | $34M | $35M | $15M | |
| PP&E (Gross) | $294M | $284M | $250M | $234M | $219M | $179M | $133M | $111M | $77M | $61M | $61M | $35M | |
| Accum. Depreciation | $209M | $190M | $158M | $132M | $110M | $93M | $69M | $50M | $41M | $27M | $27M | $20M | |
| Goodwill | $524M | $523M | $523M | $523M | $527M | $211M | $199M | $198M | $147M | $147M | $147M | $3M | |
| Intangibles | $287M | $340M | $373M | $408M | $442M | $121M | $127M | $140M | $74M | $77M | $88M | $4M | |
| Other Non-current Assets | $9M | $6M | $5M | $5M | $7M | $5M | $3M | $3M | $891.0K | $174.0K | $129.0K | $141.0K | |
| Total Assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Accounts Payable | $23M | $22M | $20M | $21M | $18M | $25M | $20M | $18M | $10M | $17M | $12M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $88M | $301M | $96M | $90M | $87M | $73M | $64M | $61M | $36M | $38M | $40M | $15M | |
| Capital Leases | $63M | $61M | $68M | $69M | $72M | $42M | $24M | $5M | $5M | $5M | $5M | $5M | |
| Deferred Tax | $18M | $22M | $24M | $35M | $55M | $5M | $16M | $22M | $7M | · | $16M | $821.0K | |
| Other Non-current Liabilities | $12M | $12M | $13M | $13M | $14M | $4M | $4M | $3M | $283.0K | · | · | · | |
| Total Liabilities | $523M | $736M | $740M | $742M | $762M | $294M | $202M | $185M | $140M | $151M | $113M | $21M | |
| Long-term Debt | $342M | $541M | $538M | · | · | · | · | $102M | $97M | $98M | $55M | · | |
| Total Debt | $342M | $541M | · | · | · | $0 | · | · | $95M | · | $53M | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | $60.0K | |
| Retained Earnings | $-434M | $-326M | $-247M | $-159M | $-15M | $-7M | $-11M | $-19M | $-58M | $-52M | $-22M | $-19M | |
| Treasury Stock | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $-206.0K | $-2M | $-4M | $-638.0K | $10.0K | $-2M | $-579.0K | $274.0K | · | · | · | |
| Stockholders' Equity | $837M | $902M | $942M | $998M | $1.11B | $694M | $507M | $320M | $172M | $162M | $209M | $60M | |
| Liabilities + Equity | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Shares Outstanding | 128,989,152 | 128,145,333 | 127,369,142 | 126,913,992 | 124,107,500 | 112,075,474 | 104,781,236 | 94,465,440 | 80,462,574 | 78,571,158 | 75,820,307 | 60,242,818 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $26M | $20M | $16M | $16M | $16M | $7M | $5M | |
| Stock-based Comp | $41M | $33M | $25M | $25M | $22M | $10M | $10M | $7M | $6M | $5M | $3M | $641.0K | |
| Deferred Tax | $-3M | $-3M | $-10M | $-15M | $-7M | $-18M | $-4M | $2M | $-2M | $-2M | $-2M | · | |
| Amort. of Intangibles | $32M | $33M | $35M | $34M | $23M | $10M | $10M | $6M | $7M | $7M | $412.0K | $295.0K | |
| Restructuring | $0 | $7M | $11M | $5M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $5M | $7M | $-2M | $-66M | $-27M | $1M | $23M | $45M | $18M | $21M | $6M | $9M | |
| CapEx | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $8M | $2M | $4M | |
| Investing Cash Flow | $-12M | $13M | $77M | $517.0K | $-632M | $-159M | $-20M | $-140M | $-14M | · | · | · | |
| Stock Issued | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | $9M | $3M | · | · | $34M | |
| Net Stock Activity | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-200M | $5M | $5M | $12M | $725M | $236M | $159M | $92M | $-4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | $78M | $163M | $-3M | $296.0K | $-11M | $-10M | $29M | |
| Taxes Paid | $515.0K | $207.0K | $175.0K | $180.0K | $148.0K | $246.0K | $319.0K | $-31.0K | $284.0K | $290.0K | · | · | |
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M | $-28M | $3M | · | $4M | · | $4M | · | |
| Levered FCF | · | · | $-37M | $-98M | $-94M | $-26M | $-5M | · | · | · | $4M | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | · | · | · | 875.1% | · | |
| Operating Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| Net Margin | -14.8% | -11.9% | -14.9% | -28.3% | -1.7% | 0.94% | 2.0% | · | · | · | -50.7% | · | |
| Pretax Margin | -15.2% | -12.2% | -16.4% | -31.3% | -3.1% | -3.2% | 0.89% | · | · | · | -89.8% | · | |
| EBITDA Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| ROA | -7.2% | -4.7% | -5.1% | -8.0% | -0.58% | 0.49% | 1.3% | · | -0.25% | · | -1.1% | · | |
| ROE | -12.8% | -8.7% | -9.3% | -14.3% | -0.74% | 0.61% | 1.6% | · | -0.50% | · | -1.9% | · | |
| ROIC | -9.6% | -6.2% | -10.4% | -14.3% | -5.9% | 0.60% | 5.6% | · | 0.21% | · | -1.2% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 | 6.1 | 4.5 | · | 2.4 | · | 2.5 | · | |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 | 4.6 | 4.2 | · | 2.1 | · | 1.8 | · | |
| Debt / Equity | 0.4 | 0.6 | · | · | · | 0.0 | · | · | 0.5 | · | 0.3 | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | · | · | · | · | · | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -15.6 | -104.7 | -23.4 | -2.0 | 3.5 | · | · | · | -6.6 | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.5 | 0.7 | · | · | · | 0.0 | · | |
| Inventory Turnover | 14.9 | 14.6 | 14.3 | 13.5 | 11.2 | 11.8 | 18.4 | · | 20.1 | · | 14.5 | · | |
| Receivables Turnover | 4.7 | 4.7 | 4.7 | 4.4 | 4.4 | 4.4 | 4.8 | · | · | · | 0.1 | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.53 | $7.08 | $7.42 | $8.04 | $9.89 | $6.63 | $5.37 | · | $2.15 | · | $2.76 | · | |
| Revenue / Share | $5.68 | $5.22 | $4.71 | $4.10 | $4.04 | $3.98 | $3.95 | · | · | · | $0.08 | · | |
| Cash Flow / Share | $0.04 | $0.06 | $-0.02 | $-0.53 | $-0.22 | $0.01 | $0.23 | · | $0.23 | · | $0.11 | · | |
| Cash / Share | $1.25 | $2.88 | $2.70 | $2.12 | $2.83 | $2.18 | $1.83 | · | $0.16 | · | $0.31 | · | |
| EPS (TTM) | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.04 | $0.02 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 11.7% | 16.1% | 5.2% | 9.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.6% | 10.9% | 10.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Net Income TTM | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| Market Cap | $1.51B | $2.10B | $2.05B | $1.15B | $3.82B | $5.64B | $2.76B | · | $713M | · | $597M | · | |
| Enterprise Value | $1.69B | $2.27B | · | · | · | $5.41B | · | · | $795M | · | $626M | · | |
| P/E | -49.0 | -68.7 | -67.4 | -38.5 | -142.2 | -224.3 | -121.9 | -52.5 | -36.9 | -35.7 | -196.8 | 208.5 | |
| P/S | 2.1 | 3.2 | 3.5 | 2.2 | 7.9 | 12.7 | 6.8 | · | 3.0 | · | 119.3 | · | |
| P/B | 1.8 | 2.3 | 2.2 | 1.1 | 3.5 | 8.1 | 5.4 | · | 4.1 | · | 2.8 | · | |
| P / Tangible Book | 58.7 | 52.6 | 45.0 | 17.1 | 27.5 | 15.6 | · | · | · | · | · | · | |
| P / Cash Flow | 288.1 | 298.9 | -1051.4 | -17.4 | -143.1 | 3864.0 | 118.2 | · | 39.5 | · | 93.3 | · | |
| P / FCF | -69.2 | -61.7 | -66.9 | -11.8 | -42.1 | -204.1 | 827.3 | · | 164.0 | · | 142.8 | · | |
| EV / EBITDA | -14.6 | -24.7 | · | · | · | -386.8 | · | · | 342.1 | · | -111.1 | · | |
| EV / FCF | -77.6 | -66.8 | · | · | · | -195.9 | · | · | 182.9 | · | 149.9 | · | |
| EV / Revenue | 2.3 | 3.4 | · | · | · | 12.2 | · | · | 3.3 | · | 125.2 | · | |
| Earnings Yield | -2.0% | -1.5% | -1.5% | -2.6% | -0.70% | -0.45% | -0.82% | -1.9% | -2.7% | -2.8% | -0.51% | 0.48% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $202M | $187M | $190M | $188M | $181M | $168M | $172M | $168M | $165M | $156M | $156M | $152M | $147M | $137M | $139M | $129M | |
| Cost of Revenue | $110M | $106M | $107M | $107M | $104M | $95M | $95M | $93M | $92M | $91M | $88M | $90M | $87M | $82M | $82M | $80M | |
| Gross Profit | $92M | $81M | $83M | $80M | $77M | $73M | $77M | $75M | $72M | $65M | $68M | $62M | $60M | $55M | $57M | $49M | |
| R&D Expense | $11M | $10M | $9M | $9M | $9M | $10M | $8M | $8M | $8M | $8M | $7M | $5M | $8M | $7M | $7M | $7M | |
| SG&A Expense | $64M | $66M | $64M | $70M | $72M | $68M | $64M | $67M | $63M | $66M | $60M | $61M | $60M | $62M | $55M | $64M | |
| Operating Expenses | $102M | $99M | $97M | $107M | $125M | $101M | $96M | $96M | $94M | $96M | $86M | $87M | $90M | $90M | $83M | $88M | |
| Operating Income | $-10M | $-18M | $-13M | $-27M | $-48M | $-28M | $-18M | $-21M | $-22M | $-31M | $-19M | $-24M | $-30M | $-35M | $-26M | $-40M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $-3M | $-3M | $2M | · | $139.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | · | · | |
| Other Non-op | $-17.0K | $-12.0K | $84.0K | $-335.0K | $482.0K | $65.0K | $-431.0K | $317.0K | $-2.0K | $-263.0K | $124.0K | $-96.0K | $730.0K | $-114.0K | $-1.0K | $25.0K | |
| Pretax Income | $2M | $-18M | $-12M | $-26M | $-46M | $-26M | $-16M | $-18M | $-19M | $-28M | $-15M | $-21M | $-27M | $-34M | $-26M | $-40M | |
| Income Tax | $-412.0K | $-472.0K | $-3M | $740.0K | $-724.0K | $266.0K | $-804.0K | $-150.0K | $-375.0K | $-620.0K | $-960.0K | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Net Income | $2M | $-17M | $-10M | $-27M | $-45M | $-26M | $-15M | $-18M | $-19M | $-27M | $-14M | $-19M | $-24M | $-31M | $-23M | $-37M | |
| Shares (Basic) | 129,628,000 | 129,166,000 | · | 128,415,000 | 127,949,000 | 127,376,000 | · | 126,953,000 | 126,405,000 | 126,111,000 | · | 125,687,000 | 125,356,000 | 125,026,000 | · | 124,425,000 | |
| Shares (Diluted) | 130,831,000 | 129,166,000 | · | 128,415,000 | 127,949,000 | 127,376,000 | · | 126,953,000 | 126,405,000 | 126,111,000 | · | 125,687,000 | 125,356,000 | 125,026,000 | · | 124,425,000 | |
| EBITDA | $-10M | $-18M | · | $-27M | $-48M | $-28M | · | $-21M | $-22M | $-31M | · | $-24M | $-30M | $-35M | · | $-40M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $146M | $146M | $160M | $164M | $155M | $346M | $367M | $362M | $355M | $332M | · | $306M | $289M | $276M | · | $266M | |
| Receivables | $175M | $167M | $159M | $155M | $153M | $151M | $151M | $151M | $147M | $140M | · | $133M | $125M | $119M | · | $112M | |
| Inventory | $27M | $30M | $29M | $28M | $34M | $30M | $27M | $24M | $23M | $20M | · | $24M | $25M | $24M | · | $24M | |
| Prepaid Expense | $24M | $24M | $21M | $22M | $23M | $23M | $20M | $18M | $17M | $19M | · | $19M | $17M | $16M | · | $17M | |
| Other Current Assets | $10M | $7M | $7M | $11M | $10M | $12M | $12M | $8M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Current Assets | $381M | $374M | $376M | $382M | $393M | $574M | $596M | $590M | $584M | $574M | · | $587M | $585M | $585M | · | $603M | |
| PP&E (Net) | $81M | $84M | $85M | $85M | $85M | $90M | $94M | $93M | $92M | $88M | · | $95M | $100M | $103M | · | $107M | |
| PP&E (Gross) | · | · | $294M | · | · | · | $284M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $223M | $216M | $209M | $209M | $201M | $199M | $190M | $181M | $176M | $168M | · | $155M | $147M | $139M | · | $125M | |
| Goodwill | $524M | $524M | $524M | $524M | $524M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | · | $523M | |
| Intangibles | $271M | $279M | $287M | $294M | $302M | $331M | $340M | $348M | $356M | $365M | · | $382M | $391M | $399M | · | $417M | |
| Other Non-current Assets | $9M | $10M | $9M | $8M | $7M | $6M | $6M | $6M | $4M | $4M | · | $5M | $5M | $5M | · | $7M | |
| Total Assets | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Accounts Payable | $21M | $26M | $23M | $23M | $27M | $16M | $22M | $17M | $17M | $18M | · | $17M | $18M | $23M | · | $14M | |
| Current Liabilities | $106M | $85M | $88M | $98M | $100M | $280M | $301M | $296M | $290M | $77M | · | $93M | $95M | $87M | · | $85M | |
| Capital Leases | $65M | $61M | $63M | $64M | $67M | $60M | $61M | $62M | $63M | $65M | · | $62M | $65M | $67M | · | $70M | |
| Deferred Tax | $17M | $17M | $18M | $21M | $20M | $21M | $22M | $23M | $23M | $23M | · | $25M | $29M | $32M | · | $38M | |
| Other Non-current Liabilities | $862.0K | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | · | $13M | $13M | $13M | · | $14M | |
| Total Liabilities | $567M | $518M | $523M | $536M | $540M | $713M | $736M | $733M | $727M | $717M | · | $731M | $739M | $735M | · | $743M | |
| Long-term Debt | · | · | $342M | · | · | · | $541M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $374M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-449M | $-451M | $-434M | $-424M | $-397M | $-352M | $-326M | $-310M | $-293M | $-274M | · | $-233M | $-214M | $-190M | · | $-136M | |
| Treasury Stock | $25M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $4.0K | $4.0K | $71.0K | $29.0K | $-56.0K | $-206.0K | $-643.0K | $-1M | $-1M | · | $-2M | $-3M | $-3M | · | $-5M | |
| Stockholders' Equity | $786M | $829M | $837M | $838M | $854M | $888M | $902M | $908M | $916M | $923M | $942M | $947M | $956M | $974M | $998M | $1.01B | |
| Liabilities + Equity | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Shares Outstanding | 127,917,946 | 129,653,642 | 128,145,333 | 128,885,101 | 128,681,713 | 128,356,327 | 128,145,333 | 128,061,944 | 127,851,113 | 127,434,786 | 127,369,142 | 127,261,476 | 127,144,418 | 127,200,491 | 126,913,992 | 126,562,037 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $10M | $8M | $10M | $12M | $11M | $8M | $0 | $9M | $8M | $7M | $0 | $6M | $5M | $5M | $4M | |
| Amort. of Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $8M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $1M | $2M | $3M | $5M | · | $0 | |
| Operating Cash Flow | $20M | $-8M | $1M | $9M | $20M | $-25M | $10M | $9M | $14M | $-26M | $18M | $-5M | $-2M | $-13M | $-4M | $-16M | |
| CapEx | $8M | $5M | $8M | $8M | $6M | $4M | $12M | $11M | $13M | $6M | $7M | $4M | $7M | $10M | $5M | $8M | |
| Investing Cash Flow | $-8M | $-5M | $-6M | $-277.0K | $-9M | $4M | $-5M | $-4M | $7M | $15M | $17M | $21M | $15M | $24M | $-1M | $-4M | |
| Stock Issued | $2M | $-338.0K | $431.0K | $765.0K | $-1M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $93.0K | $1M | $2M | $3M | |
| Net Stock Activity | · | $-338.0K | · | · | · | $949.0K | · | · | · | $816.0K | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-12M | $-338.0K | $431.0K | $765.0K | $-202M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $64.0K | $1M | $2M | $3M | |
| Net Change in Cash | · | · | · | $9M | · | · | · | $7M | $23M | $-11M | · | $17M | $13M | $12M | · | $-18M | |
| Taxes Paid | $711.0K | $0 | $57.0K | $0 | $458.0K | $0 | $-112.0K | $143.0K | $87.0K | $89.0K | $0 | $0 | $175.0K | $0 | $25.0K | $26.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-30M | · | · | · | $-32M | · | · | · | $-23M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-33M | · | · | · | · | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.6% | 43.3% | · | 42.8% | 42.6% | 43.6% | · | 44.6% | 44.1% | 41.9% | · | 41.0% | 40.8% | 40.0% | · | 38.0% | |
| Operating Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| Net Margin | 1.1% | -9.2% | · | -14.4% | -24.9% | -15.4% | · | -10.5% | -11.3% | -17.3% | · | -12.2% | -16.6% | -22.4% | · | -28.6% | |
| Pretax Margin | 0.91% | -9.4% | · | -14.1% | -25.3% | -15.3% | · | -10.6% | -11.6% | -17.7% | · | -14.1% | -18.1% | -24.6% | · | -30.8% | |
| EBITDA Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| ROA | 0.16% | -1.2% | · | -1.8% | -3.0% | -1.6% | · | -1.1% | -1.1% | -1.6% | · | -1.1% | -1.4% | -1.7% | · | -2.0% | |
| ROE | 0.27% | -2.0% | · | -3.1% | -5.1% | -2.9% | · | -1.9% | -2.0% | -2.9% | · | -1.9% | -2.4% | -3.0% | · | -3.4% | |
| ROIC | -1.0% | -2.1% | · | -3.3% | -5.5% | -3.2% | · | -2.3% | -2.4% | -3.2% | · | -2.2% | -2.9% | -3.3% | · | -3.6% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.4 | · | 3.9 | 3.9 | 2.1 | · | 2.0 | 2.0 | 7.5 | · | 6.3 | 6.2 | 6.8 | · | 7.1 | |
| Quick Ratio | 3.0 | 3.7 | · | 3.3 | 3.1 | 1.8 | · | 1.7 | 1.7 | 6.2 | · | 4.7 | 4.4 | 4.6 | · | 4.4 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.1 | · | 8.5 | 11.8 | · | · | -284.2 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 3.6 | 3.6 | · | 4.1 | 3.6 | 3.8 | · | 3.8 | 3.8 | 4.1 | · | 3.7 | 3.7 | 3.4 | · | 3.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.14 | $6.39 | · | $6.50 | $6.64 | $6.92 | · | $7.09 | $7.16 | $7.25 | · | $7.44 | $7.52 | $7.66 | · | $8.00 | |
| Revenue / Share | $1.54 | $1.45 | · | $1.46 | $1.42 | $1.32 | · | $1.32 | $1.30 | $1.24 | · | $1.21 | $1.17 | $1.10 | · | $1.03 | |
| Cash Flow / Share | · | $-0.06 | · | · | · | $-0.20 | · | · | · | $-0.21 | · | · | · | $-0.10 | · | · | |
| Cash / Share | $1.14 | $1.13 | · | $1.27 | $1.20 | $2.70 | · | $2.83 | $2.78 | $2.60 | · | $2.41 | $2.27 | $2.17 | · | $2.10 | |
| EPS (TTM) | $-0.24 | $-0.24 | · | $-0.24 | $-0.24 | $-0.24 | · | $-0.24 | $-0.24 | $-0.24 | · | $-0.24 | $-0.24 | $-0.24 | · | $-0.24 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $766M | $746M | · | $709M | $689M | $672M | · | $644M | $628M | $611M | · | $575M | $552M | $530M | · | $497M | |
| Net Income TTM | $-52M | $-99M | · | $-113M | $-104M | $-78M | · | $-78M | $-79M | $-84M | · | $-96M | $-115M | $-126M | · | $-163M | |
| Market Cap | $1.87B | $962M | · | $995M | $941M | $1.22B | · | $1.89B | $1.77B | $2.00B | · | $1.57B | $2.04B | $2.21B | · | $1.09B | |
| Enterprise Value | $2.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -60.8 | -30.9 | · | -32.2 | -30.5 | -39.5 | · | -61.5 | -57.8 | -65.5 | · | -51.2 | -67.0 | -72.5 | · | -35.9 | |
| P/S | 2.4 | 1.3 | · | 1.4 | 1.4 | 1.8 | · | 2.9 | 2.8 | 3.3 | · | 2.7 | 3.7 | 4.2 | · | 2.2 | |
| P/B | 2.4 | 1.2 | · | 1.2 | 1.1 | 1.4 | · | 2.1 | 1.9 | 2.2 | · | 1.7 | 2.1 | 2.3 | · | 1.1 | |
| P / Tangible Book | · | 37.2 | · | 50.3 | 33.5 | 35.6 | · | 50.5 | 48.3 | 55.8 | · | 36.6 | 47.8 | 42.4 | · | 14.9 | |
| P / Cash Flow | · | -118.2 | · | · | · | -48.1 | · | · | · | -77.3 | · | · | · | -174.5 | · | · | |
| EV / Revenue | 2.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.6% | -3.2% | · | -3.1% | -3.3% | -2.5% | · | -1.6% | -1.7% | -1.5% | · | -1.9% | -1.5% | -1.4% | · | -2.8% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $727M | $661M | $592M | $510M | $484M |
| Marża Brutto % | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% |
| Marża Operacyjna % | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% |
| Zysk netto | $-108M | $-79M | $-88M | $-144M | $-8M |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.4 | 0.6 | · | · | · |
| Wskaźnik bieżący | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 |
| Wskaźnik Szybkości | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-22M | $-34M | $-31M | $-97M | $-91M |
Właściciele instytucjonalni (13F) 296 emitentów · $2.4B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
296
Wartość posiadanych akcji
$2.4B
Nowe pozycje
58
Zamknięte pozycje
38
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 58 (+9 vs poprzedni kw.) | 38 (+2 vs poprzedni kw.) | 100 (+22 vs poprzedni kw.) | 61 (-22 vs poprzedni kw.) | +19.6M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $304 469 400 | 20 868 362 | 12,94% | Akcje |
| First Light Asset Management, LLC | $179 158 241 | 12 279 523 | 7,61% | Akcje |
| VANGUARD GROUP INC | $162 621 455 | 13 828 355 | 6,91% | Akcje |
| FIRST TRUST ADVISORS LP | $147 552 477 | 10 113 261 | 6,27% | Akcje |
| Greenhouse Funds LLLP | $125 097 724 | 8 574 210 | 5,32% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117 615 272 | 8 061 362 | 5,00% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $84 082 418 | 5 763 017 | 3,57% | Akcje |
| STATE STREET CORP | $78 257 609 | 5 363 784 | 3,33% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $73 501 000 | 5 037 787 | 3,12% | Akcje |
| BRAIDWELL LP | $71 756 567 | 4 918 202 | 3,05% | Akcje |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $61 886 083 | 4 342 883 | 2,63% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50 558 727 | 3 465 300 | 2,15% | Opcja kupna |
| GEODE CAPITAL MANAGEMENT, LLC | $50 025 999 | 3 428 123 | 2,13% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $44 930 518 | 3 079 542 | 1,91% | Akcje |
| TORONTO DOMINION BANK | $43 770 000 | 3 000 000 | 1,86% | Opcja kupna |
| LOOMIS SAYLES & CO L P | $37 025 291 | 2 537 717 | 1,57% | Akcje |
| Driehaus Capital Management LLC | $36 604 049 | 2 508 845 | 1,56% | Akcje |
| BANK OF AMERICA CORP /DE/ | $35 546 038 | 2 436 329 | 1,51% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $35 003 708 | 2 399 411 | 1,49% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $34 896 129 | 2 391 784 | 1,48% | Akcje |
| AMERICAN CAPITAL MANAGEMENT INC | $32 648 145 | 2 237 707 | 1,39% | Akcje |
| UBS Group AG | $32 581 659 | 2 233 150 | 1,38% | Opcja kupna |
| D. E. Shaw & Co., Inc. | $32 021 519 | 2 194 758 | 1,36% | Akcje |
| SAMLYN CAPITAL, LLC | $31 096 207 | 2 131 337 | 1,32% | Akcje |
| Aberdeen Group plc | $28 180 950 | 1 931 525 | 1,20% | Akcje |
| MORGAN STANLEY | $27 693 709 | 1 898 128 | 1,18% | Akcje |
| GOLDMAN SACHS GROUP INC | $22 859 028 | 1 566 760 | 0,97% | Akcje |
| NORTHERN TRUST CORP | $22 456 651 | 1 539 181 | 0,95% | Akcje |
| GLENMEDE TRUST CO NA | $22 141 579 | 1 517 586 | 0,94% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17 689 018 | 1 212 407 | 0,75% | Akcje |
| SEGALL BRYANT & HAMILL, LLC | $15 850 518 | 1 086 396 | 0,67% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $12 685 640 | 869 475 | 0,54% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $12 149 312 | 832 715 | 0,52% | Akcje |
| Glenmede Investment Management, LP | $12 057 018 | 1 561 790 | 0,51% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $11 709 890 | 802 597 | 0,50% | Akcje |
| Bank of New York Mellon Corp | $10 743 609 | 736 368 | 0,46% | Akcje |
| CITIGROUP INC | $9 748 716 | 668 178 | 0,41% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $9 189 162 | 629 826 | 0,39% | Akcje |
| HighMark Wealth Management LLC | $8 936 871 | 612 534 | 0,38% | Akcje |
| Invesco Ltd. | $8 754 555 | 600 038 | 0,37% | Akcje |
| UBS Group AG | $8 391 672 | 575 166 | 0,36% | Akcje |
| JPMORGAN CHASE & CO | $8 363 938 | 581 091 | 0,36% | Akcje |
| JUPITER ASSET MANAGEMENT LTD | $7 841 935 | 537 487 | 0,33% | Akcje |
| Public Sector Pension Investment Board | $6 526 545 | 447 330 | 0,28% | Akcje |
| Trexquant Investment LP | $6 358 074 | 435 783 | 0,27% | Akcje |
| Nuveen, LLC | $6 172 300 | 423 050 | 0,26% | Akcje |
| Granite Investment Partners, LLC | $5 181 507 | 355 141 | 0,22% | Akcje |
| AMERIPRISE FINANCIAL INC | $4 625 865 | 317 057 | 0,20% | Akcje |
| RHUMBLINE ADVISERS | $4 624 054 | 316 935 | 0,20% | Akcje |
| Legal & General Group Plc | $4 317 503 | 295 922 | 0,18% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| IRS IDENTIFICATION NO. NeoGenomics, Inc. | 12 kwietnia 2007 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 52 insiderów · 31 dyrektorzy generalni · 23 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Anthony P. Zook | Chief Executive Officer | 1 kwietnia 2026 M | 133 111 | 0 | 0 | $0 |
| Christopher M Smith | Chief Executive Officer | 23 lutego 2025 M | 641 585 | 0 | 0 | $0 |
| Mark Mallon | Chief Executive Officer | 1 marca 2022 A | 368 051 | 0 | 0 | $0 |
| Jeffrey Scott Sherman | Chief Financial Officer | 23 lutego 2026 M | 220 009 | 0 | 0 | $0 |
| William Bonello | Chief Financial Officer | 28 kwietnia 2022 M | 191 548 | 0 | 0 | $0 |
| Sharon Virag | Chief Financial Officer | 1 marca 2019 A | 10 944 | 0 | 0 | $0 |
| Vishal Sikri | President Advanced Diagnostics | 23 lutego 2024 A | 127 716 | 0 | 0 | $0 |
| David Sholehvar | President, Clinical Services | 1 sierpnia 2022 A | 43 216 | 0 | 0 | $0 |
| George Cardoza | President & COO, Lab Ops | 2 marca 2022 F | 244 157 | 0 | 0 | $0 |
| Gina M Wallar | President, Pharma Services | 1 marca 2022 A | 33 443 | 0 | 0 | $0 |
| Clive Morris | President of Inivata | 30 grudnia 2021 A | 41 280 | 0 | 0 | $0 |
| Robert J. Shovlin | President, Clinical Services | 25 maja 2021 M | 150 101 | 0 | 0 | $0 |
| Warren Stone | Pres & Chief Operating Officer | 21 sierpnia 2026 M | 181 078 | 0 | 1 | $-276 600 |
| Alicia C Olivo | EVP, GC & Business Development | 1 września 2026 F | 90 875 | 0 | 2 | $-300 172 |
| Greg D Aunan | Chief Accounting Officer | 4 sierpnia 2026 S | 5 153 | 0 | 1 | $-321 400 |
| Melody Harris | Chf Ops Off, Pres, Informatics | 23 lutego 2025 M | 109 755 | 0 | 0 | $0 |
| Shashikant Kulkarni | Chief Scientific Officer | 1 kwietnia 2023 F | 82 673 | 0 | 0 | $0 |
| Cynthia J Dieter | Chief Accounting Officer | 2 marca 2023 F | 29 765 | 0 | 0 | $0 |
| Douglas Matthew Brown | Chief Strategy Officer | 1 kwietnia 2022 A | 158 684 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Legal Officer | 1 marca 2022 A | 147 396 | 0 | 0 | $0 |
| Kathryn B Mckenzie | Chief Sustainability/Risk Ofcr | 11 stycznia 2022 M | 49 361 | 0 | 0 | $0 |
| Jennifer Balliet | VP and Chief Culture Officer | 30 grudnia 2021 A | 48 615 | 0 | 0 | $0 |
| Lawrence Martin Weiss | Chief Medical Officer | 22 kwietnia 2021 M | 130 847 | 0 | 0 | $0 |
| Denise E Pedulla | General Counsel | 2 marca 2021 A | 60 643 | 0 | 0 | $0 |
| Steven G. Brodie | VP - Pharma Operations | 22 października 2018 M | 45 953 | 0 | 0 | $0 |
| Steven A Ross | CIO | 10 maja 2018 X | 4 500 | 0 | 0 | $0 |
| Maher Albitar | Chief Medical Officer | 25 maja 2017 A | 60 692 | 0 | 0 | $0 |
| Mark Alan Machulcz | Vice President of Operations | 28 stycznia 2016 A | · | 0 | 0 | $0 |
| Robert H. Horel | Vice President GM PathLogic | 29 grudnia 2015 X | 51 218 | 0 | 0 | $0 |
| Robert P Gasparini | Chief Science Officer | 22 maja 2014 X | 8 439 | 0 | 0 | $0 |
| Mark W Smits | Chief Commercial Officer | 18 maja 2011 M | 0 | 0 | 0 | $0 |
| Carolyn S Starrett | Dyrektor | 23 czerwca 2026 A | · | 0 | 0 | $0 |
| Lynn A. Tetrault | Dyrektor | 15 czerwca 2026 S | 86 115 | 0 | 2 | $-118 824 |
| Marjorie C Green | Dyrektor | 1 czerwca 2026 A | 22 964 | 0 | 0 | $0 |
| Neil Gunn | Dyrektor | 1 czerwca 2026 A | 51 177 | 0 | 0 | $0 |
| Michael Aaron Kelly | Dyrektor | 1 czerwca 2026 A | 67 086 | 0 | 0 | $0 |
| David Brian Perez | Dyrektor | 1 czerwca 2026 A | 56 967 | 0 | 0 | $0 |
| John P. Kenny | Dyrektor | 1 czerwca 2026 A | 5 893 | 0 | 0 | $0 |
| Stephen M Kanovsky | Dyrektor | 1 czerwca 2026 A | 75 421 | 0 | 0 | $0 |
| Felicia Williams | Dyrektor | 1 czerwca 2026 A | 30 237 | 0 | 0 | $0 |
| Elizabeth Floegel | Dyrektor | 1 czerwca 2025 A | 23 590 | 0 | 0 | $0 |
| Alison L. Hannah | Dyrektor | 1 czerwca 2025 M | 131 023 | 0 | 0 | $0 |
| Bruce K Crowther | Dyrektor | 10 sierpnia 2023 A | 65 120 | 0 | 0 | $0 |
| Rachel A Stahler | Dyrektor | 10 czerwca 2022 A | 21 335 | 0 | 0 | $0 |
| David Daly | Dyrektor | 10 czerwca 2022 A | 17 179 | 0 | 0 | $0 |
| Kevin C Johnson | Dyrektor | 22 grudnia 2021 M | 37 398 | 0 | 0 | $0 |
| Douglas M Van Oort | Dyrektor | 1 sierpnia 2021 F | 2 468 797 | 0 | 0 | $0 |
| Steven C Jones | Dyrektor | 7 stycznia 2021 M | 90 218 | 0 | 0 | $0 |
| Raymond R Hipp | Dyrektor | 16 listopada 2020 S | 66 800 | 0 | 0 | $0 |
| William J Robison | Dyrektor | 25 maja 2017 A | 183 348 | 0 | 0 | $0 |
| Michael T Dent | Dyrektor | 4 grudnia 2014 S | 1 384 150 | 0 | 0 | $0 |
| Peter M Peterson | Dyrektor | 5 czerwca 2012 A | 34 500 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 51 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,27% | 123 482 SH | 1 października 2026 | Dziennie |
| PTH · Invesco Exchange-Traded Fund Trust | 1,23% | 246 967 SH | 1 października 2026 | Dziennie |
| XSMO · Invesco Exchange-Traded Fund Trust | 0,84% | 1 312 803 SH | 1 października 2026 | Dziennie |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,71% | 601 468 NS | 31 lipca 2026 | N-PORT |
| IHF · iShares Trust | 0,34% | 250 331 SH | 11 września 2026 | Dziennie |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,27% | 239 159 NS | 31 lipca 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,16% | 19 929 SH | 1 października 2026 | Dziennie |
| NUSC · Nushares ETF Trust | 0,15% | 126 293 NS | 31 lipca 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,14% | 54 487 NS | 31 lipca 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 180 254 SH | 1 października 2026 | Dziennie |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,12% | 89 895 SH | 19 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 104 297 SH | 19 sierpnia 2026 | Dziennie |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,10% | 455 144 SH | 19 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,09% | 146 435 SH | 11 września 2026 | Dziennie |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,09% | 116 046 SH | 19 sierpnia 2026 | Dziennie |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 33 444 NS | 31 lipca 2026 | N-PORT |
| IWM · iShares Trust | 0,08% | 3 367 792 SH | 11 września 2026 | Dziennie |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,08% | 34 215 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,07% | 40 558 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,06% | 63 019 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 757 699 SH | 19 sierpnia 2026 | Dziennie |
| SMDX · Tidal Trust III | 0,05% | 4 493 NS | 31 lipca 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,05% | 54 996 SH | 1 października 2026 | Dziennie |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 1 728 845 SH | 19 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,04% | 358 850 NS | 31 lipca 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,03% | 388 986 SH | 19 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,03% | 10 624 SH | 11 września 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 62 331 NS | 31 lipca 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 8 379 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1 492 431 SH | 19 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,02% | 2 990 594 SH | 19 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,01% | 115 979 SH | 11 września 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,01% | 344 253 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 15 340 NS | 31 lipca 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12 627 SH | 19 sierpnia 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,01% | 14 534 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 30 125 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 47 070 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 172 474 SH | 11 września 2026 | Dziennie |
| TILT · FlexShares Trust | 0,00% | 4 536 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 35 356 SH | 10 września 2026 | Dziennie |
| IXUS · iShares Trust | 0,00% | 56 854 SH | 11 września 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4 136 535 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10 236 SH | 19 sierpnia 2026 | Dziennie |
| IJR · iShares Trust | · | 7 951 677 SH | 10 września 2026 | Dziennie |
| IJT · iShares Trust | · | 716 232 SH | 9 września 2026 | Dziennie |
| IJS · iShares Trust | · | 490 259 SH | 8 września 2026 | Dziennie |
| IWN · iShares Trust | · | 1 129 992 SH | 11 września 2026 | Dziennie |
| XJR · iShares Trust | · | 18 003 SH | 31 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | · | 5 811 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 45 624 SH | 11 września 2026 | Dziennie |
NEO Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 16 analityków
KUP
Średni cel
$19.00
+2,9%
4 25,0%
Mocne kupno
7 43,8%
Kup
5 31,2%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
9 analityków · 2026-10-02Średnia cel $19.72 +6,8%
Teraz
Aktualna cena $18.47
Niski$16.00
Średnia$19.72
Wysoki$35.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| OPCH | $5.00B | 25.1 | 13.0% | 3.7% | 15.4% | 19.3% |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | · | · | 17.9% | 3.4% | 24.8% | 20.2% |
| PRVA | $2.93B | 131.7 | 22.3% | 1.1% | 3.3% | · |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | · |
| ADUS | · | 20.6 | 23.2% | · | · | · |
| WGS | · | · | · | · | · | · |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | · |
| AMN | $606M | -6.4 | -8.5% | -3.5% | -15.3% | 28.3% |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Lip 28, 2026